Have a personal or library account? Click to login
An expanding spectrum of complications in isolated methylmalonic aciduria Cover

An expanding spectrum of complications in isolated methylmalonic aciduria

Open Access
|Nov 2020

References

  1. Fowler B, Leonard JV, Baumgartner MR. Causes of and diagnostic approach to methylmalonic acidurias. J Inherit Metab Dis. 2008;31(3):350–60. doi:10.1007/s10545-008-0839-4.
  2. Froese DS, Fowler B, Baumgartner MR. Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation. J Inherit Metab Dis. 2019;42(4):673–85. doi:10.1002/jimd.12009.
  3. Hörster F, Garbade SF, Zwickler T, Aydin HI, Bodamer OA, Burlina AB, et al. Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters. J Inherit Metab Dis. 2009;32(5):630. doi:10.1007/s10545-009-1189-6. Epub 2009 Jul 31. Erratum in: J Inherit Metab Dis. 2009;32(6):762–3.
  4. Kölker S, Garcia-Cazorla A, Valayannopoulos V, Lund AM, Burlina AB, Sykut-Cegielska J, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis. 2015;38(6):1041–57. doi:10.1007/s10545-015-9839-3. Erratum in: J Inherit Metab Dis. 2015;38(6):1155–6. Cazorla, Angeles Garcia [corrected to Garcia-Cazorla, Angeles].
  5. Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130. doi:10.1186/s13023-014-0130-8.
  6. Oberholzer VG, Levin B, Burgess EA, Young WF. Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child. 1967;42(225):492–504. doi:10.1136/adc.42.225.492.
  7. Hörster F, Baumgartner MR, Viardot C, Suormala T, Burgard P, Fowler B, et al. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res. 2007;62(2):225–30. doi:10.1203/PDR.0b013e3180a0325f.
  8. Kölker S, Valayannopoulos V, Burlina AB, Sykut-Cegielska J, Wijburg FA, Teles EL, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis. 2015;38(6):1059–74. doi:10.1007/s10545-015-9840-x. Erratum in: J Inherit Metab Dis. 2015;38(6):1157–8. Garcia Cazorla, Angeles [corrected to Garcia-Cazorla, Angeles].
  9. Haijes HA, Jans JJM, Tas SY, Verhoeven-Duif NM, van Hasselt PM. Pathophysiology of propionic and methylmalonic acidemias. Part 1: complications. J Inherit Metab Dis. 2019;42(5):730–44. doi:10.1002/jimd.12129.
  10. Kruszka PS, Manoli I, Sloan JL, Kopp JB, Venditti CP. Renal growth in isolated methylmalonic acidemia. Genet Med. 2013;15(12):990–6. doi:10.1038/gim.2013.42.
  11. Cosson MA, Benoist JF, Touati G, Déchaux M, Royer N, Grandin L, et al. Long-term outcome in methylmalonic aciduria: a series of 30 French patients. Mol Genet Metab. 2009;97(3):172–8. doi:10.1016/j.ymgme.2009.03.006.
  12. Noone D, Riedl M, Atkison P, Avitzur Y, Sharma AP, Filler G, et al. Kidney disease and organ transplantation in methylmalonic acidaemia. Pediatr Transplant. 2019;23(4):e13407. doi:10.1111/petr.13407.
  13. Luciani A, Schumann A, Berquez M, Chen Z, Nieri D, Failli M, et al. Impaired mitophagy links mitochondrial disease to epithelial stress in methylmalonyl-CoA mutase deficiency. Nat Commun. 2020;11(1):970. doi:10.1038/s41467-020-14729-8. Erratum in: Nat Commun. 2020;11(1):1719. 10.1038/s41467-020-15565-6.
  14. de Keyzer Y, Valayannopoulos V, Benoist JF, Batteux F, Lacaille F, Hubert L, et al. Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res. 2009;66(1):91–5. doi:10.1203/PDR.0b013e3181a7c270.
  15. Manoli I, Sysol JR, Li L, Houillier P, Garone C, Wang C, et al. Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia. Proc Natl Acad Sci U S A. 2013;110(33):13552–7. doi:10.1073/pnas.1302764110.
  16. Haarmann A, Mayr M, Kölker S, Baumgartner ER, Schnierda J, Hopfer H, et al. Renal involvement in a patient with cobalamin A type (cblA) methylmalonic aciduria: a 42-year follow-up. Mol Genet Metab. 2013;110(4):472–6. doi:10.1016/j.ymg-me.2013.08.021.
  17. Prada CE, Al Jasmi F, Kirk EP, Hopp M, Jones O, Leslie ND, et al. Cardiac disease in methylmalonic acidemia. J Pediatr. 2011;159(5):862-864. doi:10.1016/j.jpeds.2011.06.005.
  18. Vatanavicharn N, Champattanachai V, Liammongkolkul S, Sawangareetrakul P, Keeratichamroen S, Ketudat Cairns JR, et al. Clinical and molecular findings in Thai patients with isolated methylmalonic acidemia. Mol Genet Metab. 2012;106(4):424–9. doi:10.1016/j.ymgme.2012.05.012.
  19. Ktena YP, Paul SM, Hauser NS, Sloan JL, Gropman A, Manoli I, et al. Delineating the spectrum of impairments, disabilities, and rehabilitation needs in methylmalonic acidemia (MMA). Am J Med Genet A. 2015;167A(9):2075–84. doi:10.1002/ajmg.a.37127.
  20. de Baulny HO, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM. Methylmalonic and propionic acidaemias: management and outcome. J Inherit Metab Dis. 2005;28(3):415–23. doi:10.1007/s10545-005-7056-1.
  21. Kahler SG, Millington DS, Cederbaum SD, Vargas J, Bond LD, Maltby DA, et al. Parenteral nutrition in propionic and methyl-malonic acidemia. J Pediatr. 1989;115(2):235–41. doi:10.1016/s0022-3476(89)80071-x.
  22. Marquard J, El Scheich T, Klee D, Schmitt M, Meissner T, Mayatepek E, et al. Chronic pancreatitis in branched-chain organic acidurias – a case of methylmalonic aciduria and an overview of the literature. Eur J Pediatr. 2011;170(2):241–5. doi:10.1007/s00431-010-1313-5.
  23. Thul PJ, Akesson L, Wiking M, Mahdessian D, Geladaki A, Blal H, et al. A subcellular map of the human proteome. Science (New York, N.Y.). 2017;356(6340):eaal3321. doi:10.1126/science. aal3321.
  24. Brassier A, Krug P, Lacaille F, Pontoizeau C, Krid S, Sissaoui S, et al. Long-term outcome of methylmalonic aciduria after kidney, liver, or combined liver-kidney transplantation: the French experience. J Inherit Metab Dis. 2020;43(2):234–43. doi:10.1002/jimd.12174.
  25. Imbard A, Garcia Segarra N, Tardieu M, Broué P, Bouchereau J, Pichard S, et al. Long-term liver disease in methylmalonic and propionic acidemias. Mol Genet Metab. 2018;123(4):433–40. doi:10.1016/j.ymgme.2018.01.009.
  26. Forny P, Hochuli M, Rahman Y, Deheragoda M, Weber A, Baruteau J, et al. Liver neoplasms in methylmalonic aciduria: an emerging complication. J Inherit Metab Dis. 2019;42(5):793–802. doi:10.1002/jimd.12143.
  27. Cosson MA, Touati G, Lacaille F, Valayannnopoulos V, Guyot C, Guest G, et al. Liver hepatoblastoma and multiple OXPHOS deficiency in the follow-up of a patient with methylmalonic aciduria. Mol Genet Metab. 2008;95(1–2):107–9. doi:10.1016/j.ymg-me.2008.06.007.
  28. Chan R, Mascarenhas L, Boles RG, Kerkar N, Genyk Y, Venkatramani R. Hepatoblastoma in a patient with methylmalonic aciduria. Am J Med Genet A. 2015;167A(3):635–8. doi:10.1002/ajmg.a.36925.
  29. Nicolaides P, Leonard J, Surtees R. Neurological outcome of methylmalonic acidaemia. Arch Dis Child. 1998;78(6):508–12. doi:10.1136/adc.78.6.508.
  30. Martín-Hernández E, Lee PJ, Micciche A, Grunewald S, Lachmann RH. Long-term needs of adult patients with organic acidaemias: outcome and prognostic factors. J Inherit Metab Dis. 2009;32(4):523–33. doi:10.1007/s10545-009-1191-12.
  31. O’Shea CJ, Sloan JL, Wiggs EA, Pao M, Gropman A, Baker EH, et al. Neurocognitive phenotype of isolated methylmalonic acidemia. Pediatrics. 2012;129(6):e1541–51. doi:10.1542/peds.2011-1715.
  32. Wajner M. Neurological manifestations of organic acidurias. Nat Rev Neurol. 2019;15(5):253–71. doi:10.1038/s41582-019-0161-9.
  33. Pinar-Sueiro S, Martínez-Fernández R, Lage-Medina S, Al-damiz-Echevarria L, Vecino E. Optic neuropathy in methylmalonic acidemia: the role of neuroprotection. J Inherit Metab Dis. 2010;33(Suppl 3):S199–203. doi:10.1007/s10545-010-9084-8.
  34. Manoli I, Myles JG, Sloan JL, Shchelochkov OA, Venditti CP. A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 1: isolated methylmalonic acidemias. Genet Med. 2016;18(4):386–95. doi:10.1038/gim.2015.102.
  35. van der Meer SB, Poggi F, Spada M, Bonnefont JP, Ogier H, Hubert P, et al. Clinical outcome and long-term management of 17 patients with propionic acidaemia. Eur J Pediatr. 1996;155(3):205–10. doi:10.1007/BF01953939.
  36. Yannicelli S, Acosta PB, Velazquez A, Bock HG, Marriage B, Kurczynski TW, et al. Improved growth and nutrition status in children with methylmalonic or propionic acidemia fed an elemental medical food. Mol Genet Metab. 2003;80(1–2):181–8. doi:10.1016/j. ymgme.2003.08.012.
  37. Molema F, Gleich F, Burgard P, van der Ploeg AT, Summar ML, Chapman KA, et al.; Additional individual contributors from E-IMD. Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: on the basis of information from a European multicenter registry. J Inherit Metab Dis. 2019;42(6):1162–75. doi:10.1002/jimd.12066.
  38. Touati G, Valayannopoulos V, Mention K, de Lonlay P, Jouvet P, Depondt E, et al. Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture. J Inherit Metab Dis. 2006;29(2–3):288–98. doi:10.1007/s10545-006-0351-7.
  39. Diodato D, Olivieri G, Pro S, Maiorani D, Martinelli D, Deodato F, et al. Axonal peripheral neuropathy in propionic acidemia: a severe side effect of long-term metronidazole therapy. Neurology. 2018;91(12):565–7. doi:10.1212/WNL.0000000000006209.
  40. Goolsby TA, Jakeman B, Gaynes RP. Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature. Int J Antimicrob Agents. 2018;51(3):319–25. doi:10.1016/j.ijantimicag.2017.08.033.
  41. Alston TA, Abeles RH. Enzymatic conversion of the antibiotic metronidazole to an analog of thiamine. Arch Biochem Biophys. 1987;257(2):357–62. doi:10.1016/0003-9861(87)90577-7.
  42. Kapoor K, Chandra M, Nag D, Paliwal JK, Gupta RC, Saxena RC. Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res. 1999;19(3):83–8.
  43. Forny P, Schumann A, Mustedanagic M, Mathis D, Wulf MA, Nägele N, et al. Novel mouse models of methylmalonic aciduria recapitulate phenotypic traits with a genetic dosage effect. J Biol Chem. 2016;291(39):20563–73. doi:10.1074/jbc. M116.747717.
  44. Lucienne M, Aguilar-Pimentel JA, Amarie OV, Becker L, Calzada-Wack J, da Silva-Buttkus P, et al. In-depth phenotyping reveals common and novel disease symptoms in a hemizygous knock- in mouse model (Mut-ko/ki) of mut-type methylmalonic aciduria. Biochim Biophys Acta Mol Basis Dis. 2020;1866(3):165622. doi:10.1016/j.bbadis.2019.165622.
DOI: https://doi.org/10.34763/jmotherandchild.20202402si.2014.000003 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488
Language: English
Page range: 9 - 13
Published on: Nov 10, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Patrick Forny, Stephanie Grunewald, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.